Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528221 | 12552822 | 1 | I | 20150813 | 20160630 | 20160713 | 20160713 | EXP | PHHY2016DE095607 | NOVARTIS | 0.00 | E | M | Y | 64.00000 | KG | 20160713 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528221 | 12552822 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 800 MG, QD | U | 22068 | 800 | MG | QD | ||||||
| 125528221 | 12552822 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, QD | U | 22068 | 400 | MG | QD | ||||||
| 125528221 | 12552822 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 800 MG, QD | U | 22068 | 800 | MG | QD | ||||||
| 125528221 | 12552822 | 4 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, QD | U | 22068 | 400 | MG | QD | ||||||
| 125528221 | 12552822 | 5 | SS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, QD | U | 22068 | 400 | MG | QD | ||||||
| 125528221 | 12552822 | 6 | C | ZOPICLON | ZOPICLONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 7 | C | OMEP | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 8 | C | DEXAMETASON | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 9 | C | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 10 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 11 | C | AMOXI | AMOXICILLIN | 1 | Unknown | UNK | 0 | ||||||||||
| 125528221 | 12552822 | 12 | C | HUMAN INSUNORM | 2 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125528221 | 12552822 | 1 | Chronic myeloid leukaemia |
| 125528221 | 12552822 | 6 | Product used for unknown indication |
| 125528221 | 12552822 | 7 | Product used for unknown indication |
| 125528221 | 12552822 | 8 | Product used for unknown indication |
| 125528221 | 12552822 | 9 | Product used for unknown indication |
| 125528221 | 12552822 | 10 | Product used for unknown indication |
| 125528221 | 12552822 | 11 | Product used for unknown indication |
| 125528221 | 12552822 | 12 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125528221 | 12552822 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125528221 | 12552822 | 1 | 20150803 | 0 | ||
| 125528221 | 12552822 | 2 | 20150815 | 0 | ||
| 125528221 | 12552822 | 3 | 20150903 | 0 | ||
| 125528221 | 12552822 | 4 | 20151104 | 0 | ||
| 125528221 | 12552822 | 5 | 20160212 | 0 | ||
| 125528221 | 12552822 | 6 | 20151127 | 0 | ||
| 125528221 | 12552822 | 7 | 20151127 | 0 | ||
| 125528221 | 12552822 | 8 | 20151127 | 0 | ||
| 125528221 | 12552822 | 9 | 20160108 | 0 | ||
| 125528221 | 12552822 | 10 | 20160115 | 0 | ||
| 125528221 | 12552822 | 11 | 20160122 | 20160201 | 0 | |
| 125528221 | 12552822 | 12 | 20160202 | 0 |